Categories: News

Carrum Health Names Bryan Chen as Senior Vice President, User Growth

SAN FRANCISCO, Dec. 16, 2021 /PRNewswire/ — Carrum Health, the first digital health company connecting employers and employees to Centers of Excellence (COEs) through a technology-powered platform, today announced that Bryan Chen has been named as senior vice president, User Growth. An early employee and former executive at Vida Health who accelerated the digital health company’s growth as its head of business development and strategy, Chen will work cross functionally across Carrum Health’s various functions to enhance user growth and COE utilization.

“Carrum Health is accelerating the transition to outcomes-based care, and we want to ensure that our members can optimize their healthcare experience by accessing the highest quality, most affordable care,” said Sach Jain, CEO and founder of Carrum Health. “Chen brings unique experience as a multifaceted executive who has been at the forefront of the digital health revolution. He will leverage this expertise to ensure that our marketing, provider, patient, client success and data teams work in concert to deliver the most impactful experiences to our members.”

Chen was one of the first 20 employees and member of the executive leadership team at Vida Health, joining as the first business hire after the company’s Series A funding. During his six year tenure through its Series D, Chen led business development, strategy, and built the foundation for many of its earliest functions and capabilities, including client success,  marketing, sales operations, pricing, legal, and payer channels. Prior to Vida Health, he was a management consultant in the healthcare practice at McKinsey & Co., primarily focusing on strategy, business development, mergers with clients that included payers, state governments, providers, and biotech and pharma companies. At the forefront of episode-based payment models, he designed bundles for several states, including Arkansas, Tennessee, and Ohio as part of initiatives supported by the Center for Medicare and Medicaid Innovation Center. Chen earned a Ph.D. in Molecular Biology from Stanford University and a Bachelor’s degree in Biology from Cornell University. 

“Hearing that you need surgery, then trying to navigate the complex system to find a doctor you can trust, is a nerve-wracking and overwhelming experience for most people. There is no doubt that Carrum Health’s ability to provide access to the best surgeons and hospitals across the country, simplify how the care is paid for, and provide exceptional personalized guidance along the way, is changing the equation for patients,” said Chen. “I look forward to helping Carrum Health’s rapidly growing base of self-insured employers and their employees find a pathway to the best and most effective care.”

Chen’s hiring comes on the heels of other key executive hirings in the last quarter, including former Google executive Pallav Sharda joining as Chief Platform Officer and former ConsumerMedical executive Randy K. Hawkins, M.D. joining as Chief Medical Officer. Earlier this month, Carrum Health was recognized among an elite group of innovative digital health startups and named to the CB Insights Digital Health 150.

About Carrum Health 
Carrum Health was founded in 2014 with a mission to “bring common sense to healthcare” through a value-based healthcare model that benefits families, employers and providers. Headquartered in South San Francisco, Carrum’s award-winning surgery benefits platform connects self-insured employers with top providers under standardized bundled payment arrangements to better manage healthcare costs. By aligning provider incentives with quality performance, Carrum drives improvements in patient experience and health outcomes. Customers include Fortune 500 companies and public sector organizations. For more information, visit carrumhealth.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/carrum-health-names-bryan-chen-as-senior-vice-president-user-growth-301446188.html

SOURCE Carrum Health

Staff

Recent Posts

GSK and CureVac to Restructure Collaboration into New Licensing Agreement

GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza…

2 hours ago

CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities

Strategic restructuring includes a workforce reduction of approximately 30%, re-focusing on research, development, and innovation…

2 hours ago

MedMira Reports Third Quarter Results FY2024

HALIFAX, NS / ACCESSWIRE / July 2, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today…

5 hours ago

Rapid Dose Therapeutics Announces Payment in Shares for Interest on Secured Debt

Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT"…

9 hours ago

Aveanna Healthcare Notifies Individuals of Data Security Incident

ATLANTA, July 2, 2024 /PRNewswire/ -- Aveanna Healthcare ("Aveanna") has learned of a data security…

11 hours ago